Stockholders' Equity Attributable to Parent of Cordyceps Sunshine Biotech Holdings Co., Ltd. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Stockholders' Equity Attributable to Parent in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • Cordyceps Sunshine Biotech Holdings Co., Ltd. Stockholders' Equity Attributable to Parent for the quarter ending 31 Dec 2024 was $375,543, a 147% decline year-over-year.
Source SEC data
View on sec.gov
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $375,543 -$223,747 -147% 31 Dec 2024 20-F 13 Jun 2025 2024 FY
Q4 2023 $151,796 +$799,538 +84% 31 Dec 2023 20-F/A 23 Sep 2025 2023 FY
Q3 2023 $182,939 -$300,025 -256% 30 Sep 2023 6-K 13 Nov 2023 2023 Q3
Q4 2022 $951,334 -$675,521 -245% 31 Dec 2022 20-F/A 23 Sep 2025 2023 FY
Q3 2022 $117,086 30 Sep 2022 6-K 13 Nov 2023 2023 Q3
Q4 2021 $275,813 -$263,001 -2053% 31 Dec 2021 20-F/A 23 Sep 2025 2023 FY
Q4 2020 $12,812 31 Dec 2020 20-F/A 23 Sep 2025 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.